Browse > Article

Use of Information Component (IC) and Relative Risk (RR) for Signal Detection of Drug Interactions of Clopidogrel : Data-mining Study Using Health Insurance Review & Assessment Service (HIRA) Claims Database  

Kim, Jin-Hyung (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Choi, Chung-Am (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Oh, Jung-Mi (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Son, Sung-Ho (Department of Pahrmacy, Kyungpook National University Hospital)
Shin, Wan-Gyoon (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Publication Information
Korean Journal of Clinical Pharmacy / v.21, no.2, 2011 , pp. 90-99 More about this Journal
Abstract
Health Insurance Review & Assessment Service (HIRA) claims database has a high potential to detect signals of new drug interactions. The aim of this study was to evaluate the usefulness of information component (IC) and relative risk (RR) as a tool for signal detection, and to analyze the possible drug interactions caused by clopidogrel using HIRA claims database. This study was performed in elderly patients over 65 years of age who administered clopidogrel from January 2005 to June 2006 in South Korea. Serious Adverse Events (SAEs) as drug interactions of clopidogrel were defined as any ambulatory hospitalization for ischemic diseases within comcomitant medication period of clopidogrel. Information Component (IC) and Relative Risk (RR) were calculated to compare the proportion of drug-SAE pairs in order to select drug specific SAEs. IC and RR signals of clopidogrel drug interaction were screened when IC's 95% confidence interval was greater than 0 and RR's 95% confidence interval was greater than 1 respectively. All detected signals were compared to references such as $Micromedex^{(R)}$ and 2010 Drug Interaction $Facts^{TM}$. Sensitivity, specificity, positive predicted value and negative predicted value were used to evaluate usefulness of this method. Among 13,252,930 cases of elderly patients who co-administered clopidogrel and other drugs, 47,485 cases were detected as SAE. Of these, one-hundred nine cases were detected by the IC-based data-mining approach and ninety one cases were detected by the RR-based data-mining approach. Total One-hundred sixty three unrecognized signals were detected by IC or RR. Twelve signals from IC-based data-mining (57.1%) were corresponded with drug interactions from references and eight signals from RR-based data-mining (38.1%) were corresponded with drug interactions from references. These signals include proton pump inhibitors, calcium channel blockers and HMG CoA reductase Inhibitors, which were known to affect CYP450 metabolism. Further studies using HIRA claims database are necessary to develop appropriate data-mining measure.
Keywords
clopidogrel; data-mining; drug interactions; Health Insurance Review & Assessment Service (HIRA);
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 최남경, 박병주. 우리나라 약물유해반응 감시체계. J Prev Med Public Health 2007; 40(4): 278-284.   DOI
2 Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf. 2003; 12(1): 17-29.   DOI   ScienceOn
3 Choi N, Chang Y, Choi YK, Hahn S, Park B. Signal detection of rosuvastatin compared to other statins: Datamining study using national health insurance claims database. Pharmacoepidemiol Drug Saf. 2010; 19(3): 238- 246.   DOI   ScienceOn
4 Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: The need for a balanced perspective. Drug Saf. 2005; 28(10): 835-842.   DOI   ScienceOn
5 김예지, 정선영, 최남경, 김화정, 김주영, 장유수, 성종미, 이중엽, 박병주. 우리나라 외래 노인 환자의 벤조다이아제핀 처방양상. JPERM 2008; 1: 59-66.
6 최남경, 김윤이, 이승미, 박병주. 부산지역 의원급 외래 노인 골관절염환자의 비스테로이드소염제 사용양상평가. J Prev Med Public Health 2004; 37(2): 150-156.
7 IMS. Top 15 global products 2009. 2009.
8 Mega JL, Close SL, Wiviott SD et al.,, Cytochrome P-450 Polymorphisms and Response to Clopidogrel. N Engl J Med 2009; 360(4): 354-362.   DOI   ScienceOn
9 Kreutz RP, Stanek EJ, Aubert R et al., Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study. Pharmacotherapy. 2010; 30(8): 787-796.   DOI   ScienceOn
10 Ho PM, Maddox TM, Wang L et al., Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome. JAMA. 2009; 301(9): 937-944.   DOI   ScienceOn
11 Gilard M, Arnaud B, Cornily JC, et al., Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin: The Randomized, Double-Blind Ocla (Omeprazole Clopidogrel Aspirin) Study. J Am Coll Cardiol. 2008; 51(3): 256-260.   DOI   ScienceOn
12 Kreutz RP, Stanek EJ, Aubert R et al., Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study. Pharmacotherapy. 2010; 30(8): 787-796.   DOI   ScienceOn
13 Hauben M, Zhou X. Quantitative methods in pharmacovigilance: Focus on signal detection. Drug saf. 2003; 26(3): 159-186.   DOI   ScienceOn
14 Bate A, Lindquist M, Edwards IR et al., A bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998; 54: 315-321.   DOI   ScienceOn
15 Gould AL. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol Drug Saf 2003; 12(7): 559-574.   DOI   ScienceOn
16 Lindquist M, Sthl M, Bate A, Edwards IR, Meyboom RH. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf. 2000; 23(6): 533-542.   DOI   ScienceOn
17 Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001; 10: 483-486.   DOI   ScienceOn
18 Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf. 2005 ; 4(5): 929-948.   DOI   ScienceOn
19 Neubauer H, Engelhardt A, Krger JC et al., pantoprazole does not influence the antiplatelet effect of clopidogrel. J Cardiovasc Pharmacol. 2010; 56: 91-97.   DOI   ScienceOn